MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors

D. Santos, T. de Deus, E. Suárez, L. Vela, M. Catalán, M. Álvarez Sauco, I. Gastón, M. Avila, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Seijo, C. Valero, J. González, S. Jesús, Ll. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, I. González Aramburu, V. Nogueira, C. Borrué, B. Solano, S. Escalante, E. Cubo, F. Carrillo, J. Kulisevsky, L. López Manzanares, M. Kurtis, M. Kurtis, P. Mir, P. Martínez Martín (A Coruña, Spain)

Meeting: MDS Virtual Congress 2020

Abstract Number: 775

Keywords: Depression, Obsessive-compulsive behavior/disorder, Parkinsonism

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: To analyze quality of life (QoL) in Parkinson´s disease (PD) patients regarding to have depression, impulsive-compulsive behaviors (ICBs), or both.

Background: Depression and ICBs are both common in PD patients, and their coexistence is frequent. This relationship between mood and ICBs is important due to the fact that both impact negatively on quality of life (QoL) of the patient.

Method: PD patients recruited from 35 centers of Spain from the COPPADIS cohort (1,2) from January/2016, to November/2017, were included in the study. The QUIP-RS was used for screening impulse control disorders (ICDs) (cutoff points: gambling ≥6, buying ≥8, sex≥8, eating≥7) and compulsive behaviors (CBs) (cutoff points: hobbyism-punding ≥7). Mood was assessed with the BDI-II and QoL with the PDQ-39 (health-related), PQ-10 and EUROHIS-QOL8 (global) questionnaires. QoL was determined in different groups: 1) PD patients without depression and ICB (n=266); 2) PD patients with depression but without ICBs (n=242); 2) PD patients with ICBs but without depression (n=35); 4) PD patients with both depression and ICBs (n=69). A patient suffering from at least 1 ICD and/or CB was considered as a patient with ICBs.

Results: Considering the four groups, QoL was worse in those patients with both depression and ICBs (figure 1-analysis A). QoL was worse in patients with depression and ICBs vs those with ICBs but not depression (figure 1-analysis C). However, when patients with depression but not ICBs vs those with ICBs but not depression were compared, only global QoL was significantly worse in the first group (figure 1-analysis D). Health-related and global QoL was worse in patients with depression and ICBs vs those with only depression (figure 1-analysis B): PDQ-39SI, 25.7±15.5 vs 20.6±13.1 (p=0.020); EUROHIS-QOL8, 3.4±0.5 vs 3.6±0.5 (p=0.021). Only health-related QoL was related to number of ICBs in both groups, PD patients with (p=0.009) and without depression (p=0.001) (figure 2; a trend of significance for EUROHIS-QO8 was observed [p value of 0.052 and 0.057, respectively).

Conclusion: In PD patients with depression, to suffer from ICBs could be associated with a worse QoL. In depressed PD patients, it is advisable to ask about ICBs and viceversa.

Figure 1.MDS.ABSTRACT

Figure 2.MDS.ABSTRACT

References: 1) Santos-García D, Mir P, Cubo E, et al.; COPPADIS Study Group. COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global–clinical evaluations, serum biomarkers, genetic studies and neuroimaging–prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression. BMC Neurol 2016;;16:26. 2) Santos García D, Jesús S, Aguilar M, et al.; COPPADIS Study Group. COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015): an ongoing global Parkinson’s disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation. Eur J Neurol 2019;26:1399-1407.

To cite this abstract in AMA style:

D. Santos, T. de Deus, E. Suárez, L. Vela, M. Catalán, M. Álvarez Sauco, I. Gastón, M. Avila, P. Sánchez Alonso, M. Alonso Losada, N. López Ariztegui, M. Seijo, C. Valero, J. González, S. Jesús, Ll. Planellas, J. García Caldentey, N. Caballol, B. Vives, J. Hernández Vara, I. Cabo, I. González Aramburu, V. Nogueira, C. Borrué, B. Solano, S. Escalante, E. Cubo, F. Carrillo, J. Kulisevsky, L. López Manzanares, M. Kurtis, M. Kurtis, P. Mir, P. Martínez Martín. Quality of Life in Parkinson´s Disease Patients with Depression and Impulsive-compulsive Behaviors [abstract]. Mov Disord. 2020; 35 (suppl 1). https://www.mdsabstracts.org/abstract/quality-of-life-in-parkinsons-disease-patients-with-depression-and-impulsive-compulsive-behaviors/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2020

MDS Abstracts - https://www.mdsabstracts.org/abstract/quality-of-life-in-parkinsons-disease-patients-with-depression-and-impulsive-compulsive-behaviors/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley